The U.S. partner SK Biopharma is given an EMA sleepiness node.

SK Biopharmaceuticals is a global pharmaceutical company that develops new medicines to support medical innovation. As part of our quest for the SK Group next-generation rising engine, SK Biopharmaceuticals started to research and the development of new drugs in 1993. The spirited rise of SK Biop...

Pharmaceutical dealings after Brexit

The prospect of the UK leaving the EU, and the jurisdiction of the European’s unified single marketplace for medicinal drug regulation, is creating large uncertainty for drugmakers.

What are the regulatory implications of Brexit?

Several steps have been taken to make thi...